Purpose To study the efficacy of topical cyclosporin A in children with vernal keratoconjunctivitis in a prospective randomised double-masked trial.
Methods Twenty-four children between 5 and 16 years of age were randomly treated with cyclosporin A (CsA) and placebo (vehicle) and followed up for 4 months.
Results Of the 12 patients given CsA, 11 showed symptomatic improvement by 7 days of starting treatment whereas only 3 patients in the placebo group showed mild symptomatic improvement.
Conclusions Topical cyclosporin is a safe and effective treatment in vernal keratoconjunctivitis.
BenEzra D, Peer J, Brodsky M, Cohen E . Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis. Am J Ophthalmol 1986;101:278–82.
Caldwell DR, Verin P . Efficacy and safety of lodoxamide 0.1% versus cromolyn sodium 4% in patients with vernal keratoconjunctivitis. Eye 1992;113:632–7.
Buckley DC, Caldwell DR, Reaves TA . Treatment of vernal keratoconjunctivitis with suprofan, a topical non-steroidal anti-inflammatory agent. Invest Ophthalmol Vis Sci 1993;38:133–40.
Abelson MB, Butrus SI, Weston JH . Aspirin therapy in vernal conjunctivitis. Am J Ophthalmol 1983;95:502.
Secchi A, Tognon S, Leonardi A . Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol 1990;110:641–5.
Hingorani M, Moodaley L, Calder VL, Buckley RJ, Lightman S . A randomised, placebo-controlled trial of topical cyclosporin A in steroid dependent atopic keratoconjunctivitis. Ophthalmology 1998;105:1715–20.
Bleik JH, Tabbara KF . Topical cyclosporine in vernal keratoconjunctivitis. Ophthalmology 1991;98:1679–84.
About this article
Graefe's Archive for Clinical and Experimental Ophthalmology (2019)
Expert Opinion on Orphan Drugs (2017)
Incorporation of drug particles for extended release of Cyclosporine A from poly-hydroxyethyl methacrylate hydrogels
European Journal of Pharmaceutics and Biopharmaceutics (2017)
Journal of American Association for Pediatric Ophthalmology and Strabismus (2017)
Comparative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in the Treatment of Vernal Keratoconjunctivitis